Blood Flow Restriction Training in Tennis Elbow
elbow
Effects of Blood Flow Restriction Training on Pain, Function, Disability, Quality of Life, and Common Extensor Tendon Thickness and Echogenicity in Patients With Lateral Epicondylitis: A Prospective Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Lateral epicondylitis (LE) is a common musculoskeletal disorder caused by repetitive overuse of the forearm extensor muscles. It is characterized by pain over the lateral epicondyle of the humerus, which may radiate to the surrounding tissues at the origin of the wrist extensor tendons. LE is one of the most frequent causes of lateral elbow pain, with a reported prevalence of approximately 1-3% in the general population. Among conservative interventions, exercise-based rehabilitation is considered a cornerstone of management. In particular, exercise programs incorporating eccentric contractions have demonstrated superior clinical outcomes compared with several other exercise approaches and are therefore widely recommended. Blood flow restriction training (BFRT) has recently emerged as an alternative rehabilitation strategy that promotes neuromuscular adaptations while using low mechanical loads. BFRT involves the application of a pneumatic cuff, tourniquet, or elastic band around the proximal portion of an extremity to partially restrict arterial inflow while substantially reducing venous return, thereby creating localized metabolic and hemodynamic stress during exercise. The primary aim of this randomized controlled trial was to investigate the effects of BFRT on pain, functional status, pain-free grip strength, health-related quality of life, and ultrasonographic characteristics of the common extensor tendon in patients with lateral epicondylitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedFirst Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 17, 2026
CompletedJuly 21, 2026
May 1, 2025
1 year
July 14, 2026
July 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-Rated Tennis Elbow Evaluation (PRTEE)
The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a disease-specific, patient-reported outcome measure designed to assess pain and functional disability associated with lateral epicondylitis (14,15). The questionnaire consists of two domains evaluating pain and functional limitations, with a total score ranging from 0 to 100, where higher scores indicate greater pain and disability. The Turkish version of the PRTEE has demonstrated satisfactory validity and reliability
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Secondary Outcomes (4)
Visual Analog Scale (VAS)
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Pain-free grip strength (PFGS) Assessment
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Health-Related Quality of Life
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Ultrasonographic Evaluation of the Common Extensor Tendon
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Study Arms (2)
Blood flow restriction training (BFRT) group
EXPERIMENTALThe exercise program in this group was performed under blood flow restriction using a pneumatic cuff positioned around the proximal portion of the affected upper arm.
Control group
ACTIVE COMPARATORParticipants in the control group performed the same exercise protocol without blood flow restriction.
Interventions
Both groups participated in a supervised exercise program consisting of 12 sessions over four weeks (three sessions per week), with each session lasting approximately 45 minutes. Each treatment session began with 3-5 minutes of transverse friction massage applied to the painful region, followed by gentle circular soft-tissue mobilization in a proximal-to-distal direction. Resistance exercises were then performed using dumbbells and consisted of concentric and eccentric wrist extension and forearm supination exercises. The order of exercises was standardized for all participants throughout the intervention period. Participants allocated to the BFRT group performed the exercise program under blood flow restriction using a pneumatic cuff positioned around the proximal portion of the affected upper arm. Before the intervention, arterial occlusion pressure (AOP) was individually determined for each participant. The cuff pressure used during training was set at 50% of the individual AOP. Tot
Participants in the control group performed the identical exercise protocol without blood flow restriction.
Eligibility Criteria
You may qualify if:
- age between 18 and 75 years;
- clinical diagnosis of lateral epicondylitis based on medical history and physical examination;
- pain intensity of ≥4 on a 10-cm Visual Analog Scale (VAS) during daily activities;
- provision of written informed consent.
You may not qualify if:
- hypertension, diabetes mellitus, cardiovascular disease, peripheral vascular disease, previous deep vein thrombosis, or lymphedema;
- orthopedic, rheumatologic, or neurological disorders affecting the upper extremity;
- fibromyalgia;
- congenital or acquired elbow deformity;
- previous trauma, fracture, or surgery involving the affected upper extremity;
- cervical radiculopathy or peripheral neuropathy affecting the involved limb;
- receipt of any treatment for lateral epicondylitis within the preceding 3 months;
- skin lesions, infection, or open wounds at the cuff application site;
- bleeding disorders or current anticoagulant therapy;
- pregnancy;
- active malignancy or a history of malignancy;
- cognitive impairment or neurological or psychiatric disorders that could interfere with comprehension of study procedures or completion of outcome assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Necmettin Erbakan University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Konya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
SAMİ KÜÇÜKŞEN, Professor
Necmettin Erbakan University, Faculty of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 17, 2026
Study Start
February 28, 2025
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
July 21, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Starting 6 months after publication- ending 2 years after the publication of results
- Access Criteria
- Journal editors or reviewers may request this information from the corresponding author's email address if they deem it necessary.
All collected IPD, all IPD that underlie results in a publication